GLP-1 receptor agonists (like Ozempic, Wegovy, and Rybelsus, which all contain the active ingredient semaglutide) are medications that mimic what natural GLP-1 does, helping support your body when it needs a little extra help
Electrolyte imbalances represent another potential contributing factor
However, it is important to note that, due to potential underreporting by the informants, there were also instances of unknown indications ( n = 2,281, 27.68%)
Your appetite suppression and weight loss trajectory matter more than the presence of digestive adjustments
Adults with type 2 diabetes prescribed semaglutide were matched, 1:2, with adults prescribed a non-GLP-1 diabetes drug, and adults with overweight or obesity prescribed semaglutide were matched, 1:2, with adults prescribed a non-GLP-1 obesity medication
e , Representative bright field images of glucose-deprived vector- or AMPK-expressing H1299 cells pretreated with indicated -KG competitors